Support Alert

Class 2 medicines recall: Ranitidine 150mg and 300mg tablets

Medreich Plc is recalling all unexpired stock of ranitidine 150mg and 300mg tablets from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society